![Mohammad Hirmand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Il dott. Mohammad Hirmand, MD, è direttore medico e vicepresidente esecutivo di Turning Point Therapeutics, Inc. Il dott. Hirmand è stato precedentemente impiegato come vicepresidente dello sviluppo clinico presso Medivation LLC (California), direttore associato della ricerca clinica presso Amgen, Inc., direttore senior dello sviluppo clinico presso ARCA biopharma, Inc., manager dello sviluppo del mercato e della valutazione dei prodotti presso Innoviva, Inc, un Senior Director-Clinical Development di Nuvelo, Inc., un Chief Medical Officer di Peloton Therapeutics, Inc., un Director-Oncology Development di SuperGen, Inc., un Principal di Theravance Biopharma US, Inc. e un Manager-Clinical Data di Tularik, Inc. Si è laureato alla Cornell University e ha conseguito il dottorato alla Harvard Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 27/03/2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Fondatore | 01/08/2022 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| TURG POIN | Direttore Tecnico/Scientifico/R&S | 01/08/2022 |
| PELOTON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 31/12/2019 |
| MEDIVATION INC | Direttore operativo | 01/10/2015 |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Corporate Officer/Principal | - |
| ARCA BIOPHARMA | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
